Lymphedema-related angiogenic tumors and other malignancies

Clinics in Dermatology

Volumn 32, Issue 5, 2014, Pages 616-620

  Lee, Robert ^a   Saardi, Karl M ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSARCOMA; BASAL CELL CARCINOMA; CARCINOGENESIS; CELLULAR IMMUNITY; DISEASE ASSOCIATION; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOPATHOLOGY; KAPOSI SARCOMA; LYMPHANGIOGENESIS; LYMPHANGIOSARCOMA; LYMPHEDEMA; MELANOMA; MERKEL CELL TUMOR; NON MELANOMA SKIN CANCER; NOTE; PATIENT MONITORING; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOMA; SKIN LYMPHOMA; STEWART TREVES SYNDROME; COMPLICATION; IMMUNOLOGY; SKIN TUMOR;

HEMANGIOSARCOMA; HUMANS; LYMPHEDEMA; SKIN NEOPLASMS;

EID: 84906335878     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2014.04.008     Document Type: Note

References (85)

1. Ruocco V., Schwartz R.A., Ruocco E. Lymphedema: An immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002, 47:124-127.
2. Ruocco V., Ruocco E., Brunetti G., et al. Opportunistic localization of skin lesions on vulnerable areas. Clin Dermatol 2011, 29:483-488.
3. Rao R., Euhus D., Mayo H.G., et al. Axillary node interventions in breast cancer: A systematic review. JAMA 2013, 310:1385-1394.
4. Manduch M., Oliveira A.M., Nascimento A.G., et al. Massive localised lymphoedema: A clinicopathological study of 22 cases and review of the literature. J Clin Pathol 2009, 62:808-811.
5. Shon W., Ida C.M., Boland-Froemming J.M., et al. Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese: A report of five cases and review of the literature. J Cutan Pathol 2011, 38:560-564.
6. Chopra K., Tadisina K.K., Brewer M., et al. Massive localized lymphedema revisited: A quickly rising complication of the obesity epidemic. Ann Plast Surg 2013, 10.1097/SAP.0 b013 e31828 bb332.
7. Lutz M.E., Otley C.C. Rhinophyma and coexisting occult skin cancers. Dermatol Surg 2001, 27:201-202.
8. Lazzeri D., Colizzi L., Licata G., et al. Malignancies within rhinophyma: Report of three new cases and review of the literature. Aesthetic Plast Surg 2012, 36:396-405.
9. Ruocco E., Brunetti G., Brancaccio G., et al. Phlebolymphedema: Disregarded cause of immunocompromised district. Clin Dermatol 2012, 30:541-543.
10. Peyron N., Dandurand M., Guillot B. Malignant tumors as complications of lymphedema. J Mal Vasc 1993, 18:293-298.
11. Futrell J.W., Myers G.H. Regional lymphatics and cancer immunity. Ann Surg 1973, 177:1-7.
12. Witte M.H., Stuntz M., Witte C.L. Kaposi's sarcoma. A lymphologic perspective. Int J Dermatol 1989, 28:561-570.
13. Stark R., Dwyer E., DeForest M. Effect of surgical ablation of regional lymph nodes on survival of skin homografts. Ann N Y Acad Sci 1960, 87:140-148.
14. Mallon E., Powell S., Mortimer P., et al. Evidence for altered cell-mediated immunity in postmastectomy lymphoedema. Br J Dermatol 1997, 137:928-933.
15. Lukas M., Stossel H., Hefel L., et al. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J Invest Dermatol 1996, 106:1293-1299.
16. Tel J., Anguille S., Waterborg C.E., et al. Tumoricidal activity of human dendritic cells. Trends Immunol 2013, 10.1016/j.it.2013.10.007.
17. Kimura T., Sugaya M., Blauvelt A., et al. Delayed wound healing due to increased interleukin-10 expression in mice with lymphatic dysfunction. J Leukoc Biol 2013, 94:137-145.
18. Yanofsky V.R., Mitsui H., Felsen D., et al. Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy. Clin Dev Immunol 2013, 2013:624123.
19. Paul J., Carlson J.A. Lymphangiectases are common underlying warts and in normal peritumoral skin: Histologic evidence of decreased immune surveillance. Am J Dermatopathol 2011, 33:152-160.
20. Ruocco E., Puca R.V., Brunetti G., et al. Lymphedematous areas: Privileged sites for tumors, infections, and immune disorders. Int J Dermatol 2007, 46:662.
21. Olszewski W.L., Engeset A., Romaniuk A., et al. Immune cells in peripheral lymph and skin of patients with obstructive lymphedema. Lymphology 1990, 23:23-33.
22. Pfarr K.M., Debrah A.Y., Specht S., et al. Filariasis and lymphoedema. Parasite Immunol 2009, 31:664-672.
23. Cueni L.N., Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 2006, 126:2167-2177.
24. Tammela T., Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 2010, 140:460-476.
25. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-227.
26. Rockson S.G. Lymphedema. Am J Med 2001, 110:288-295.
27. Mortimer P.S. The pathophysiology of lymphedema. Cancer 1998, 83:2798-2802.
28. Saharinen P., Tammela T., Karkkainen M.J., et al. Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004, 25:387-395.
29. Löwenstein S. Der atiologische zusammenhang zwischen akutem ein-maligem trauma und sarkon. K Klin Cir 1906, 48:780-824.
30. Stewart F.W., Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948, 1:64-81.
31. Cozen W., Bernstein L., Wang F., et al. The risk of angiosarcoma following primary breast cancer. Br J Cancer 1999, 81:532-536.
32. Sharma A., Schwartz R.A. Stewart-Treves syndrome: Pathogenesis and management. J Am Acad Dermatol 2012, 67:1342-1348.
33. Durr H.R., Pellengahr C., Nerlich A., et al. Stewart-Treves syndrome as a rare complication of a hereditary lymphedema. Vasa 2004, 33:42-45.
34. Hallel-Halevy D., Yerushalmi J., Grunwald M.H., et al. Stewart-Treves syndrome in a patient with elephantiasis. J Am Acad Dermatol 1999, 41:349-350.
35. Bhagyalakshmi A., Santa Rao G., Uma P., et al. Cutaneous angiosarcoma in chronic lymphedema: Secondary to filariasis. Indian J Surg 2011, 73:384-385.
36. Kirchmann T.T., Smoller B.R., McGuire J. Cutaneous angiosarcoma as a second malignancy in a lymphedematous leg in a Hodgkin's disease survivor. J Am Acad Dermatol 1994, 31:861-866.
37. Ruocco V., Pisani M., Astarita C. Stewart-Treves syndrome with local deficit of cellular immunity: Pathogenic hypothesis. Ann Dermatol Venereol 1982, 109:489-492.
38. Aloi F., Tomasini C., Soro E., et al. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol 2000, 42:468-472.
39. Duzgun S., Pekdemir I., Yilanci S., et al. A cutaneous angiosarcoma arising from the rhinophyma. Kulak Burun Bogaz Ihtis Derg 2013, 23:344-347.
40. Gallardo M.A., Bosch R.J., Vidal L., et al. Angiosarcoma arising on rhinophyma. Eur J Dermatol 2000, 10:555-558.
41. Traaholt L., Eeg Larsen T. Rhinophyma and angiosarcoma of the nose. A case report. Scand J Plast Reconstr Surg 1978, 12:81-83.
42. Feller J.K., Mahalingam M. c-myc and cutaneous vascular neoplasms. Am J Dermatopathol 2013, 35:364-369.
43. Manner J., Radlwimmer B., Hohenberger P., et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 2010, 176:34-39.
44. Shehan J.M., Ahmed I. Angiosarcoma arising in a lymphedematous abdominal pannus with histologic features reminiscent of Kaposi's sarcoma: Report of a case and review of the literature. Int J Dermatol 2006, 45:499-503.
45. Studniberg H.M., Rivers J.K., Cooke B.E., et al. The coexistence of lymphangiosarcoma and Kaposi's sarcoma in a renal transplant recipient. Cancer 1991, 68:2330-2335.
46. Allan A.E., Shoji T., Li N., et al. Two cases of Kaposi's sarcoma mimicking Stewart-Treves syndrome found to be human herpesvirus-8 positive. Am J Dermatopathol 2001, 23:431-436.
47. Sharma-Walia N., Paul A.G., Bottero V., et al. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: A key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog 2010, 6:e1000777.
48. Bala K., Bosco R., Gramolelli S., et al. Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression. PLoS Pathog 2012, 8:e1002927.
49. Ruocco V., Astarita C., Guerrera V., et al. Kaposi's sarcoma on a lymphedematous immunocompromised limb. Int J Dermatol 1984, 23:56-60.
50. Fei L., Ruocco V., Ayala F., et al. Classical Kaposi's sarcoma. Study of the lymphatic system of lower limbs. Presse Med 1987, 16:1188-1190.
51. Ziegler J.L. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993, 342:1348-1351.
52. Schwartz R.A., Cohen J.B., Watson R.A., et al. Penile Kaposi's sarcoma preceded by chronic penile lymphoedema. Br J Dermatol 2000, 142:153-156.
53. Merimsky O., Chaitchik S. Kaposi's sarcoma on a lymphedematous arm following radical mastectomy. Tumori 1992, 78:407-408.
54. Barco D., Alegre M., Alomar A. Classic Kaposi sarcoma associated with lymphedema following arterial catheterization. Actas Dermosifiliogr 2008, 99:665-667.
55. Pantanowitz L., Duke W.H. Lymphoedematous variants of Kaposi's sarcoma. J Eur Acad Dermatol Venereol 2008, 22:118-120.
56. Schwartz R.A., Micali G., Nasca M.R., et al. Kaposi sarcoma: A continuing conundrum. J Am Acad Dermatol 2008, 59:179-206. [quiz 207-178].
57. Benson P.M., Pessoa C.M., Lupton G.P., et al. Basal cell carcinomas arising in chronic lymphedema. J Dermatol Surg Oncol 1988, 14:781-783.
58. Ueno T., Futagami A., Mitsuishi T., et al. Basal cell carcinoma arising on a chronic lymphedematous leg. J Dermatol 2009, 36:646-648.
59. Lotem M., Tamir G., Loven D., et al. Multiple basal cell carcinomas of the leg after recurrent erysipelas and chronic lymphedema. J Am Acad Dermatol 1994, 31:812-813.
60. Oliveira Gda P., Girao R.J., Soares C.T., et al. Multiple metastatic basal cell carcinoma with concurrent metastatic pleomorphic sarcoma in chronic lymphedema area-case report. An Bras Dermatol 2012, 87:899-902.
61. Ruocco V., Satriano R.A. Basal cell cancer and classic Kaposi's sarcoma in a locally immunocompromised patient. Int J Dermatol 1986, 25:594-596.
62. Gomes C.A., Magalhaes C.B., Soares C., et al. Squamous cell carcinoma arising from chronic lymphedema: Case report and review of the literature. Sao Paulo Med J 2010, 128:42-44.
63. Furukawa H., Yamamoto Y., Minakawa H., et al. Squamous cell carcinoma in chronic lymphedema: Case report and review of the literature. Dermatol Surg 2002, 28:951-953.
64. Epstein J.I., Mendelsohn G. Squamous carcinoma of the foot arising in association with long-standing verrucous hyperplasia in a patient with congenital lymphedema. Cancer 1984, 54:943-947.
65. Shelley W.B., Wood M.G. Transformation of the common wart into squamous cell carcinoma in a patient with primary lymphedema. Cancer 1981, 48:820-824.
66. Hadway P., Lynch M., Corbishley C.M., et al. Squamous cell carcinoma of the penis in a patient with chronic isolated penile lymphoedema. Urol Int 2006, 76:87-88.
67. Abhyankar S.V., Kulkarni A., Kulkarni M., et al. Squamous cell carcinoma of the penis and scrotum in a patient with chronic scrotal and penile lymphedema. Indian J Dermatol 2010, 55:387-389.
68. Lister R.K., Black M.M., Calonje E., et al. Squamous cell carcinoma arising in chronic lymphoedema. Br J Dermatol 1997, 136:384-387.
69. Rekha A., Ravi A., Venu N., et al. Malignant melanoma and filariasis: A coexistence or an association?. Int J Low Extrem Wounds 2005, 4:60-64.
70. Bartal A.H., Pinsky C.M. Malignant melanoma appearing in a post-mastectomy lymphedematous arm: A novel association of double primary tumors. J Surg Oncol 1985, 30:16-18.
71. Sarkany I. Malignant melanomas in lymphoedematous arm following radical mastectomy for breast carcinoma (an extension of the syndrome of Stewart and Treves). Proc R Soc Med 1972, 65:253-254.
72. Turk B.G., Bozkurt A., Yaman B., et al. Melanoma arising in chronic ulceration associated with lymphoedema. J Wound Care 2013, 22:74-75.
73. Grotz T.E., Mansfield A.S., Jakub J.W., et al. Regional lymphatic immunity in melanoma. Melanoma Res 2012, 22:9-18.
74. Gonzalez-Vela M.C., Gonzalez-Lopez M.A., Val-Bernal J.F., et al. Cutaneous diffuse large B-cell lymphoma of the leg associated with chronic lymphedema. Int J Dermatol 2008, 47:174-177.
75. Hills R.J., Ive F.A. Cutaneous secondary follicular centre cell lymphoma in association with lymphoedema praecox. Br J Dermatol 1993, 129:186-189.
76. Waxman M., Fatteh S., Elias J.M., et al. Malignant lymphoma of skin associated with postmastectomy lymphedema. Arch Pathol Lab Med 1984, 108:206-208.
77. Tatnall F.M., Mann B.S. Non-Hodgkin's lymphoma of the skin associated with chronic limb lymphoedema. Br J Dermatol 1985, 113:751-756.
78. Torres-Paoli D., Sanchez J.L. Primary cutaneous B-cell lymphoma of the leg in a chronic lymphedematous extremity. Am J Dermatopathol 2000, 22:257-260.
79. Baroni A., Russo T., Piccolo V., et al. Opportunistic metastatic porocarcinoma after saphenous venectomy for coronary bypass surgery. Clin Exp Dermatol 2013, 38:507-510.
80. Fergusson C.M., Copeland S.A., Horton L. Unusual sarcoma arising in lymphoedema. J R Soc Med 1985, 78:497-498.
81. Peterson C.M., Lane J.E., Guill M.A. Merkel cell carcinoma after postmastectomy lymphedema. J Am Acad Dermatol 2003, 48:983.
82. Ruocco V., Brunetti G., Puca R.V., et al. The immunocompromised district: A unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol 2009, 23:1364-1373.
83. Pyszel A., Malyszczak K., Pyszel K., et al. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 2006, 39:185-192.
84. Lee R., Micali G., Schwartz R. Lymphedema. Treatment of Skin Disease: Comprehensive Therapeutic Strategies 2013, 422-423. Saunders Elsevier, London. 4th ed. M.G. Lebwohl (Ed.).
85. Szolnoky G., Dobozy A., Kemeny L. Decongestion improves cell-mediated immunity in postmastectomy arm lymphoedema: A pilot study. J Eur Acad Dermatol Venereol 2013, 27:1579-1582.